1) Bantis C, Heering PJ, Aker S, Klein-Vehne N, Grabensee B, Ivens K. Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kidney Int. 2004 Jul; 66(1):288-94.
2) Chen A, Chen WP, Sheu LF, Lin CY. Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J Pathol. 1994 Jun; 173(2):119-26.
3) Chin HJ, Na KY, Kim SJ, Oh KH, Kim YS, Lim CS, Kim S, Chae DW. Interleukin-10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea. J Korean Med Sci. 2005 Dec; 20(6):989-93.
4) Goshen E, Livne A, Nagy J, Sarov I, Shoenfeld Y.Antinuclear autoantibodies in sera of patients with IgA nephropathy. Nephron. 1990; 55(1):33-6. .
5) Haas M. Histology and immunohistology of IgA nephropathy. J Nephrol. 2005 Nov-Dec; 18(6):676-80.
6) Huang QR, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol. 1997 Jun;34(8-9):577-82.
7) Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H, Kurokawa K.Glomerular Fc alphaR expression and disease activity in IgA nephropathy. Am J Kidney Dis. 1997 Sep; 30(3):389-96.
8) Kodama S, Suzuki M, Arita M, Mogi G. Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis.
Clin Exp Immunol. 2001 Feb; 123 (2):301-8.
9) Lim CS, Yoon HJ, Kim YS, Ahn C, Han JS, Kim S, Lee JS, Lee HS, Chae DW. Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy.
Nephrology (Carlton). 2003 Feb; 8 (1):21-7.
10) Lim CS, Zheng S, Kim YS, Ahn C, Han JS, Kim S, Lee JS, Chae DW, Koo JR, Chun RW, Noh JW.Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol Dial Transplant. 2001 Feb; 16(2):269-75.
11) Liu ZH, Cheng ZH, Yu YS, Tang Z, Li LS. Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schonlein nephritis and IgA nephropathy? Kidney Int. 1997 Jun; 51(6):1938-42.
12) Maksic D, Spasic P, Dimitrijevic J, Colic M, Hrvacevic R, Kovacevic Z, Maric M. Significance of inflammatory cytokines in the pathogenesis of IgA nephropathy Vojnosanit Pregl. 1998 Mar-Apr; 55(2):141-9.
13) Monteiro RC, Leroy V, Launay P, Moura IC, Arcos-Fajardo M, Benhamou M, Haddad E. Pathogenesis of Berger’s disease: recent advances on the involvement of immunoglobulin A and their receptors. Med Sci (Paris). 2003 Dec; 19(12):1233-41.
14) Nagy J, Goshen E, Livne A, Sarov I, Shoenfeld Y. Antinuclear antibodies in IgA nephropathy, as well as mesangiocapillary and membranous glomerulonephritis. Orv Hetil. 1991 Mar 24; 132(12):623-8.
15) Schena FP, Cerullo G, Torres DD, Scolari F, Foramitti M, Amoroso A, Pirulli D, Floege J, Mertens PR, Zerres K, Alexopoulos E, Kirmizis D, Zelante L, Bisceglia L. Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study. Eur J Hum Genet. 2006 Apr; 14(4):488-96.
16) Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int. 2000 Aug; 58(2):783-9.
17) Syrjanen J, Hurme M, Lehtimaki T, Mustonen J, Pasternack A. Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int. 2002 Mar; 61(3):1079-85.
18) Taniguchi Y, Yorioka N, Oda H, Yamakido M. Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study.Nephron. 1996; 74(4):652-60.
19) Tuglular S, Berthoux P, Berthoux F. Polymorphisms of the tumour necrosis factor alpha gene at position -308 and TNFd microsatellite in primary IgA nephropathy. Nephrol Dial Transplant. 2003 Apr; 18(4):724-31.
20) Watanabe M, Iwano M, Akai Y, Kurioka H, Nishitani Y, Harada K, Hamano K, Shiiki H. Association of interleukin-1 receptor antagonist gene polymorphism with IgA nephropathy.
Nephron. 2002 Aug; 91(4):744-6.
21) Zwirner J, Burg M, Schulze M, et al. Activated complement C3: A potentially novel predictor of progressive IgA nephropathy. Kidney Int 51: 1257-1264, 1997.